Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.184 EUR | -2.03% |
|
+2.58% | -32.54% |
06-28 | Valneva's Chikungunya Vaccine Secures Approval for Use in EU | MT |
06-26 | Valneva SE Appoints Daniele Guyot-Caparros as Board of Directors | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.54% | 475M | |
+38.65% | 39.36B | |
-8.62% | 38.52B | |
+26.95% | 30.74B | |
+10.74% | 25.92B | |
-13.50% | 26.03B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B | |
-12.61% | 10.64B |
- Stock Market
- Equities
- VLA Stock
- News Valneva
- Transcript : Valneva SE, Q1 2023 Earnings Call, May 04, 2023